Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Genetic variation of platelet glycoprotein VI and the risk of venous thromboembolism.

Skille H, Paulsen B, Hveem K, Gabrielsen ME, Brumpton B, Hindberg K, Gran OV, Rosendaal FR, Brækkan SK, Hansen JB.

Haematologica. 2019 Nov 7. pii: haematol.2019.231225. doi: 10.3324/haematol.2019.231225. [Epub ahead of print]

2.

Fibrinogen gamma gene rs2066865 and risk of cancer-related venous thromboembolism.

Paulsen B, Skille H, Smith EN, Hveem K, Gabrielsen ME, Brækkan SK, Rosendaal FR, Frazer KA, Gran OV, Hansen JB.

Haematologica. 2019 Oct 3. pii: haematol.2019.224279. doi: 10.3324/haematol.2019.224279. [Epub ahead of print]

3.

Occult cancer-related first venous thromboembolism is associated with an increased risk of recurrent venous thromboembolism.

Gran OV, Braekkan SK, Paulsen B, Skille H, Rosendaal FR, Hansen JB.

J Thromb Haemost. 2017 Jul;15(7):1361-1367. doi: 10.1111/jth.13714. Epub 2017 May 28.

4.

D-dimer measured at first venous thromboembolism is associated with future risk of cancer.

Gran OV, Brækkan SK, Paulsen B, Skille H, Hansen JB.

Haematologica. 2016 Dec;101(12):e473-e475. Epub 2016 Sep 9. No abstract available.

Supplemental Content

Loading ...
Support Center